<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In the current paper we present results of application of endoscopic time-domain OCT (<z:chebi fb="0" ids="32399">EOCT</z:chebi>) with lateral scanning by forward looking miniprobe </plain></SENT>
<SENT sid="1" pm="."><plain>We analysed material of clinical studies of 554 patients: 164 patients with urinary bladder pathology, and 390 with gastrointestinal tract pathology </plain></SENT>
<SENT sid="2" pm="."><plain>We reviewed the materials obtained in different clinics using the OCT device elaborated at the Institute of Applied Physics </plain></SENT>
<SENT sid="3" pm="."><plain>We demonstrate results of <z:chebi fb="0" ids="32399">EOCT</z:chebi> application in detection of early <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and surgery guidance, examples of combined use of OCT and fluorescence imaging </plain></SENT>
<SENT sid="4" pm="."><plain>As a result, we show the diagnostic accuracy of <z:chebi fb="0" ids="32399">EOCT</z:chebi> in specific clinical tasks </plain></SENT>
<SENT sid="5" pm="."><plain>The sensitivity of <z:chebi fb="0" ids="32399">EOCT</z:chebi> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> determination in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is from 71% to 85% at different stages of <z:hpo ids='HP_0002664'>neoplasia</z:hpo> with specificity 68% for <z:hpo ids='HP_0000001'>all</z:hpo> stages </plain></SENT>
<SENT sid="6" pm="."><plain>As for <z:hpo ids='HP_0002862'>bladder carcinoma</z:hpo>, the sensitivity and specificity are 85% and 68%, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>In <z:mp ids='MP_0000495'>colon dysplasia</z:mp> EOST demonstrates high efficacy: sensitivity 92% and specificity 84% </plain></SENT>
</text></document>